Trainings and Resources
17 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 5/26/2021 (updated 6/8/2021)
The United States is in the midst of an unprecedented opioid epidemic. In order to implement effective population-level response strategies to this epidemic, health departments and community-based organizations must understand both the size and characteristics of the local population affected. Local data regarding the opioid epidemic are sparse and don’t fully characterize the population of those most affected, such as people who inject drugs (PWID). Without these data, it is difficult to know which epidemic response strategies are meeting the most pressing community needs and whether services are delivered at the appropriate scale. For these reasons, we developed this toolkit for population size estimation with specific emphasis on applying population estimation methods among PWID in rural communities.
Posted 6/15/2020 (updated 4/1/2021)
The Opioid Use Disorder, Pregnant Women and Neonatal Abstinence Syndrome (NAS): Addressing the Challenges (Part II) webinar took place on June 9, 2020.
Considerations for Addressing Neonatal Abstinence Syndrome (NAS) Dr. Lopata, JBS NAS Technical Expert Leads, and NAS RCORP grantees from the Western Regions will discuss resources, stigma, best practices, and challenges in addressing NAS.
Integrating Health Promotion for People Who Inject Drugs (PWID) Into Opioid Use Disorder (OUD) Services The workshop will present strategies to integrate HIV, hepatitis, and sexual health concerns into services for PWID. The session will focus on communication skills, assessment techniques, and building motivation among PWID to make healthier choices. The presenter will look at programmatic and clinical-level integration strategies and offer participants an opportunity to assess current service delivery models and develop a plan to enhance care.
Over the past decade, attempts to address the overdose crisis in the U.S. have resulted in more restrictive opioid prescribing policies—which, because they have reduced the overall availability of prescription opioids, have inadvertently led to a surge in the use of illicit drugs such as heroin. To reduce the risks posed by the use or sharing of unsterile equipment (disease and infection), state governments should consider facilitating the use of syringe services programs (SSPs), which distribute free, new, sterile syringes to PWID. Such programs also often offer other services, such as vaccinations and education on preventing overdoses, and have also been shown to improve the odds that PWID will seek and engage with treatment.
Experiencing a nonfatal overdose (NFOD) is a significant risk factor for a subsequent nonfatal or fatal overdose. Overdose mortality rates in rural Appalachian states are some of the highest in the USA, but little is known about correlates of overdose among rural populations of people who inject drugs (PWID). Our study aimed to identify correlates of experiencing a recent (past 6 months) NFOD among rural PWID in Cabell County, West Virginia.
Posted 11/25/2020 (updated 2/11/2021)
The course titled, Plans of Safe Care for Infants Exposed to Opioids, educates pediatricians about best practices in caring for, and supporting families affected by prenatal opioid exposure. Advancing the care coordination and patient- and family-centered pediatric medical home framework, the course supports pediatricians in implementing key recommendations outlined in the newly released clinical report, Neonatal Opioid Withdrawal Syndrome. The topics include, (1) trends and impact of opioid use disorder (OUD) during pregnancy; (2) practical approaches for addressing social attitudes towards pregnant and parenting women with OUD; and (3) discharge planning to support long-term treatment and recovery for the mother-infant dyad during the transition to community care.
The current study examined the accuracy of sensory discernment strategies by measuring study participants’ descriptions of the last opioid injected and checked with a fentanyl test strip (FTS) by that test's positive/negative result. The primary objective was to determine associations between FTS results and descriptions of the illi it opioid's physical appearance and physiological effects.
Posted 12/23/2020 (updated 12/22/2020)
This article presents an important look into stigma of families impacted by NAS and the ways in which healthcare providers must work to combat stigma’s harmful effects, and explores directions for future research of strategies for reducing stigma amongst this population to improve engagement in healthcare and positive heath-seeking behaviors. The authors reported that mothers of infants with NAS experience intensified stigma surrounding SUDs and the challenge of overcoming exclusion, shame, and judgement of their ability to parent. In examining nurses’ perceptions of perinatal women with SUD, the authors found that many struggled with negative attitudes and prejudices towards mothers of infants with NAS that interfered with their ability to provide nonjudgmental care. The authors urge nurses to implement substantial strategies for addressing stigma through tools such as the ACTS script.